Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1CNS 1Breast 1

Conditions

Keratosis, Actinic 1Glioblastoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Imipramine × Clear all
NCT04863950 2025-08-27

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

The University of Texas Health Science Center at San Antonio

Phase 2 Recruiting
25 enrolled
CNS

Glioblastoma

NCT05688904 2024-04-24

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Wright State University

Phase 1 Recruiting
24 enrolled
Dermatologic

Keratosis, Actinic

NCT03122444 2023-06-28

Imipramine on ER+ve and Triple Negative Breast Cancer

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
17 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡